Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Recruiting · NCT06402708 · Registry updated 2026-04-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 3 | 2026-04-27 | NCT06402708 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 1 |